181 related articles for article (PubMed ID: 31201206)
1. TCPA v3.0: An Integrative Platform to Explore the Pan-Cancer Analysis of Functional Proteomic Data.
Chen MM; Li J; Wang Y; Akbani R; Lu Y; Mills GB; Liang H
Mol Cell Proteomics; 2019 Aug; 18(8 suppl 1):S15-S25. PubMed ID: 31201206
[TBL] [Abstract][Full Text] [Related]
2. Using feature selection and Bayesian network identify cancer subtypes based on proteomic data.
Wang Y; Gao X; Ru X; Sun P; Wang J
J Proteomics; 2023 May; 280():104895. PubMed ID: 37024076
[TBL] [Abstract][Full Text] [Related]
3. Explore, Visualize, and Analyze Functional Cancer Proteomic Data Using the Cancer Proteome Atlas.
Li J; Akbani R; Zhao W; Lu Y; Weinstein JN; Mills GB; Liang H
Cancer Res; 2017 Nov; 77(21):e51-e54. PubMed ID: 29092939
[TBL] [Abstract][Full Text] [Related]
4. A Multi-Method Approach for Proteomic Network Inference in 11 Human Cancers.
Şenbabaoğlu Y; Sümer SO; Sánchez-Vega F; Bemis D; Ciriello G; Schultz N; Sander C
PLoS Comput Biol; 2016 Feb; 12(2):e1004765. PubMed ID: 26928298
[TBL] [Abstract][Full Text] [Related]
5. A pan-cancer proteomic perspective on The Cancer Genome Atlas.
Akbani R; Ng PK; Werner HM; Shahmoradgoli M; Zhang F; Ju Z; Liu W; Yang JY; Yoshihara K; Li J; Ling S; Seviour EG; Ram PT; Minna JD; Diao L; Tong P; Heymach JV; Hill SM; Dondelinger F; Städler N; Byers LA; Meric-Bernstam F; Weinstein JN; Broom BM; Verhaak RG; Liang H; Mukherjee S; Lu Y; Mills GB
Nat Commun; 2014 May; 5():3887. PubMed ID: 24871328
[TBL] [Abstract][Full Text] [Related]
6. Pan-cancer identification of clinically relevant genomic subtypes using outcome-weighted integrative clustering.
Arora A; Olshen AB; Seshan VE; Shen R
Genome Med; 2020 Dec; 12(1):110. PubMed ID: 33272320
[TBL] [Abstract][Full Text] [Related]
7. miRFA: an automated pipeline for microRNA functional analysis with correlation support from TCGA and TCPA expression data in pancreatic cancer.
Borgmästars E; de Weerd HA; Lubovac-Pilav Z; Sund M
BMC Bioinformatics; 2019 Jul; 20(1):393. PubMed ID: 31311505
[TBL] [Abstract][Full Text] [Related]
8. Bayesian data integration and variable selection for pan-cancer survival prediction using protein expression data.
Maity AK; Bhattacharya A; Mallick BK; Baladandayuthapani V
Biometrics; 2020 Mar; 76(1):316-325. PubMed ID: 31393003
[TBL] [Abstract][Full Text] [Related]
9. The CPTAC Data Portal: A Resource for Cancer Proteomics Research.
Edwards NJ; Oberti M; Thangudu RR; Cai S; McGarvey PB; Jacob S; Madhavan S; Ketchum KA
J Proteome Res; 2015 Jun; 14(6):2707-13. PubMed ID: 25873244
[TBL] [Abstract][Full Text] [Related]
10. Analytical Platforms 3: Processing Samples via the RPPA Pipeline to Generate Large-Scale Data for Clinical Studies.
Siwak DR; Li J; Akbani R; Liang H; Lu Y
Adv Exp Med Biol; 2019; 1188():113-147. PubMed ID: 31820386
[TBL] [Abstract][Full Text] [Related]
11. OSppc: A web server for online survival analysis using proteome of pan-cancers.
Zhang L; Wang Q; Han Y; Huang Y; Chen T; Guo X
J Proteomics; 2023 Feb; 273():104810. PubMed ID: 36587732
[TBL] [Abstract][Full Text] [Related]
12. Proteogenomic characterization of human colon and rectal cancer.
Zhang B; Wang J; Wang X; Zhu J; Liu Q; Shi Z; Chambers MC; Zimmerman LJ; Shaddox KF; Kim S; Davies SR; Wang S; Wang P; Kinsinger CR; Rivers RC; Rodriguez H; Townsend RR; Ellis MJ; Carr SA; Tabb DL; Coffey RJ; Slebos RJ; Liebler DC;
Nature; 2014 Sep; 513(7518):382-7. PubMed ID: 25043054
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of reverse phase protein array (RPPA)-based pathway-activation profiling in 84 non-small cell lung cancer (NSCLC) cell lines as platform for cancer proteomics and biomarker discovery.
Ummanni R; Mannsperger HA; Sonntag J; Oswald M; Sharma AK; König R; Korf U
Biochim Biophys Acta; 2014 May; 1844(5):950-9. PubMed ID: 24361481
[TBL] [Abstract][Full Text] [Related]
14. LinkedOmics: analyzing multi-omics data within and across 32 cancer types.
Vasaikar SV; Straub P; Wang J; Zhang B
Nucleic Acids Res; 2018 Jan; 46(D1):D956-D963. PubMed ID: 29136207
[TBL] [Abstract][Full Text] [Related]
15. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Hoadley KA; Yau C; Hinoue T; Wolf DM; Lazar AJ; Drill E; Shen R; Taylor AM; Cherniack AD; Thorsson V; Akbani R; Bowlby R; Wong CK; Wiznerowicz M; Sanchez-Vega F; Robertson AG; Schneider BG; Lawrence MS; Noushmehr H; Malta TM; ; Stuart JM; Benz CC; Laird PW
Cell; 2018 Apr; 173(2):291-304.e6. PubMed ID: 29625048
[TBL] [Abstract][Full Text] [Related]
16. Perseus: A Bioinformatics Platform for Integrative Analysis of Proteomics Data in Cancer Research.
Tyanova S; Cox J
Methods Mol Biol; 2018; 1711():133-148. PubMed ID: 29344888
[TBL] [Abstract][Full Text] [Related]
17. Machine learning multi-omics analysis reveals cancer driver dysregulation in pan-cancer cell lines compared to primary tumors.
Sanders LM; Chandra R; Zebarjadi N; Beale HC; Lyle AG; Rodriguez A; Kephart ET; Pfeil J; Cheney A; Learned K; Currie R; Gitlin L; Vengerov D; Haussler D; Salama SR; Vaske OM
Commun Biol; 2022 Dec; 5(1):1367. PubMed ID: 36513728
[TBL] [Abstract][Full Text] [Related]
18. TCPA: a resource for cancer functional proteomics data.
Li J; Lu Y; Akbani R; Ju Z; Roebuck PL; Liu W; Yang JY; Broom BM; Verhaak RG; Kane DW; Wakefield C; Weinstein JN; Mills GB; Liang H
Nat Methods; 2013 Nov; 10(11):1046-7. PubMed ID: 24037243
[No Abstract] [Full Text] [Related]
19. Screening and bioinformatics analysis of a ceRNA network based on the circular RNAs, miRNAs, and mRNAs in pan-cancer.
Chen Z; Huang J; Feng Y; Li Z; Jiang Y
Cancer Med; 2020 Oct; 9(19):7279-7292. PubMed ID: 33094914
[TBL] [Abstract][Full Text] [Related]
20. Linking cancer genome to proteome: NCI's investment into proteogenomics.
Rivers RC; Kinsinger C; Boja ES; Hiltke T; Mesri M; Rodriguez H
Proteomics; 2014 Dec; 14(23-24):2633-6. PubMed ID: 25187343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
